Is prostate cancer prevention with selenium all in the genes? Perspective on Penney et al., p. 604

Cancer Prevention Research

Volumn 3, Issue 5, 2010, Pages 576-578

  Platz, Elizabeth A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; MANGANESE SUPEROXIDE DISMUTASE; PLACEBO; SELENIUM; SELENOPROTEIN;

BONE METASTASIS; CANCER GROWTH; CANCER RISK; CLINICAL TRIAL; GENETIC RISK; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RECURRENT CANCER; RISK REDUCTION; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER;

ANTINEOPLASTIC AGENTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELENIUM COMPOUNDS;

EID: 77952028216     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0072     Document Type: Short Survey

References (10)

1. Penney KL, Schumacher FR, Li H, et al. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res 2010;3:604-610
2. Platz EA, Lippman SM. Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial. J Clin Oncol 2009;27:3569-3572
3. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51.
4. Clark LC, Combs GF, Jr., Turnbull BW, et al. Nutritional Prevention of Cancer Study Group. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 1996;276:1957-1963
5. Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 1998;81:730-734 (Pubitemid 28316638)
6. Yoshizawa K, Willett WC, Morris SJ, et al. A study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-1224 (Pubitemid 28407088)
7. Li H, Stampfer MJ, Giovannucci EL, et al. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 2004;96:696-703. (Pubitemid 38660232)
8. Li H, Kantoff PW, Giovannucci E, et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 2005;65:2498-2504 (Pubitemid 40490163)
9. Rayman MP. Selenoproteins and human health: insights from epidemiological data. Biochim Biophys Acta 2009;1790:1533-1540
10. Hu YJ, Korotkov KV, Mehta R, et al. Distribution and functional consequences of nucleotide polymorphisms in the 3′-untranslated region of the human Sep15 gene. Cancer Res 2001;61:2307-2310 (Pubitemid 32692064)